Cita APA (7a ed.)

Libura, M., Bialopiotrowicz, E., Giebel, S., Wierzbowska, A., Roboz, G. J., Piatkowska-Jakubas, B., . . . Haus, O. (2021). IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen. Nature Portfolio.

Cita Chicago Style (17a ed.)

Libura, Marta, et al. IDH2 Mutations in Patients with Normal Karyotype AML Predict Favorable Responses to Daunorubicin, Cytarabine and Cladribine Regimen. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Libura, Marta, et al. IDH2 Mutations in Patients with Normal Karyotype AML Predict Favorable Responses to Daunorubicin, Cytarabine and Cladribine Regimen. Nature Portfolio, 2021.